Monthly Archives: March 2019

What is preclinical Alzheimer disease, and why should we care?

Every 65 seconds someone in the U.S. develops dementia. Science has not yet delivered meaningful treatments for dementia, but it is delivering on detection of preclinical dementia states (changes that are measurable in the brain but there are no symptoms yet) using biomarkers in spinal fluid and PET brain imaging.  These techniques are used currently […]

Read More